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Lymphocyte clones that are individually specific for structurally dissimilar epitopes 
can be functionally connected  through  shared  idiotypy. Although  idiotype sharing 
between antibodies binding to different epitopes was first reported in  1971 by Oudin 
and Cazenave (1), followed by repeated confirmations at the immunochemical level 
(2-12), the biological consequences of such idiotype sharing have remained relatively 
uncharted. By incorporating unspecific parallel sets into the network hypothesis, Jerne 
(13)  predicted the importance of shared idiotypy between lymphocyte clones specific 
for non-cross-reactive epitopes as a  means of  joining otherwise unconnected immune 
responses at the regulatory level. 
Experimentally, the biological relevance of unspecific parallel sets is suggested by 
studies  in  the  anti-hen-egg-white  lysozyme (HEL) t  system  (2,  3)  where  antibodies 
directed against different epitopes on the lysozyme molecule share idiotype. Produc- 
tion of these antibodies is favored by an antiidiotypic helper T  cell acting in concert 
with a classic lysozyme-specific helper T  cell. Idiotypes such as those in the anti-HEL 
system that  are coexpressed by different lymphocyte clones and that  are targets for 
regulatory signals have also been called  "regulatory idiotypes" by Bona et  al.  (14). 
Furthermore, it has been postulated that regulatory idiotypes are germ line encoded 
and  that  idiotype  dominance  during  induced  antihapten  responses  is  due  to  the 
connection of these responses with ongoing responses to environmental or endogenous 
stimuli  by  virtue  of shared  regulatory  idiotypes  (8,  15).  Idiotype sharing  between 
induced antihapten responses and naturally occurring responses has been documented 
for  the  T15  (16),  MOPC-460  (8),  and  A  strain  cross-reactive  idiotope  (CRI)"  (7) 
idiotype systems. Only  in  the  T15  system  do the  induced  and  naturally  occurring 
antibodies bind the same epitope. 
In this report, we describe our first experiments aimed toward understanding  the 
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role and extent of idiotype coupling between immune responses to non-cross-reactive 
antigens.  Our  observations  suggest  a  linkage  between  idiotype  dominance  in  an 
induced anti-p-azobenzenearsonate (ABA) antibody response and the prior occurrence 
of an  idiotypically related response that  is not specific for ABA. These experiments 
were based on a  monoclonal antiidiotype antibody ADS detecting a  new CRI family 
CRI ADs that  can  be  divided into  two  subpopulations.  One  subpopulation contains 
antibodies that are found naturally in the sera of unprimed strain A  or related mice, 
and which do not bind ABA. This subpopulation is designated as the ABA- CRI  ADS+ 
set and can be selectively expanded by immunization with a  single low dose of ADS. 
The  second  subpopulation  of  the  CRI  ADs  family,  found  in  strain  A  mice  after 
immunization with ABA-conjugated proteins, binds ABA, and is fully cross-reactive 
in the CRI"  assay. This subpopulation  is designated as the ABA  + CRI  ADS+ set and 
can be selectively stimulated by immunizations with ABA-keyhole limpet hemocyanin 
(KLH).  Regulatory  interactions  between  these  two  idiotypic  subpopulations  are 
explored. 
Materials  and  Methods 
Animals.  Strain C.AL-20 mice were generously supplied by Dr. Claudia Henry, University 
of California, Berkeley, CA, or bred in our animal colony. Nude mice on a Swiss background 
were bred and raised in the University of California, San Francisco, Animal Care Facility. All 
other mouse strains were purchased from The Jackson Laboratory, Bar Harbor, ME. Generally, 
female mice were purchased at 6 to 8 wk old and were used after acclimatization to our animal 
colony. Male Lewis rats  weighing 300-350  g  were  purchased  from  Simonsen Laboratories, 
Gilroy, CA. Female NZW rabbits were purchased from various local breeders. 
Proteins and Antigens.  KLH and human serum albumin (HSA) were purchased from Calbi- 
ochem-Behring  Corp.,  San  Diego,  CA.  Bovine  serum  albumin  (BSA)  was  purchased  from 
Sigma Chemical Co., St. Louis, MO. Brucella  abortus tube antigen, strain 1119-3, was obtained 
from the U. S. Department of Agriculture Animal and Plant Health Inspection Service, Ames, 
IA.  Azobenzenearsonate-conjugated  proteins  were  prepared  according  to  Tabachnik  and 
Sobotka (17). 
Haptens.  ABA-conjugated amino acids were generously provided by Dr. D. E. Nitecki and 
Dr. J. W. Goodman. 
Antibodies.  A/J anti-arsonate (ABA  +)  antibodies, hereafter referred to as serum idiotype, 
were purified from hyperimmune anti-ABA-KLH aseites fluid (18) by affinity chromatography 
on  columns  of ABA-BSA-Sepharose or  ABA-Tyraminyl-Affigel 10  (Bio-Rad  Laboratories, 
Richmond, CA). ABA  + antibody was eluted from the affinity matrix with either 2.5 M NaSCN 
in borate-buffered saline (BBS) or with 0.1 M p-arsarnilic acid. "Normal" A/J immunoglobulin 
(Ig)  was  purified from  complete Freund's adjuvant  (CFA)-induced ascites fluid by passage 
through ABA-BSA-Sepharose to remove any possible anti-ABA activity followed by Na2SO4 
precipitation and exclusion chromatography through Biogel A  1.5 M  (Bio-Rad Laboratories). 
Normal rat IgG and chicken gamma globulin were purified from serum (Gibco Laboratories, 
Santa Clara, CA) by Na2SO4  precipitation and chromatography on Biogel A  1.5 M. Mouse Ig 
subclasses were separated by differential pH elution from protein A-Sepharose (P-3391; Sigma 
Chemical Co.) according to Oi and Herzenberg (19).  Rat Ig were purified using ion-exchange 
chromatography (20). 
Antisera.  Rabbits were  immunized  by multiple intramuscular  inoculations containing a 
total of 1 mg of protein emulsified in CFA (Difco Laboratories, Detroit, MI). The rabbits were 
boosted at multiple subcutaneous sites twice at 2-wk intervals with  1 mg of protein per boost 
emulsified in incomplete Freund's adjuvant (IFA) (Difco Laboratories). Antisera were collected 
beginning 1 wk after the second boosting. The rabbits were subsequently boosted once a month 
and bled at various times thereafter. 
Rabbit anti-CRI  a sera were rendered idiotype specific by multiple passages through columns 
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immunosorbent assay (ELISA), in which the amount of rabbit antibody in the column effluents 
reactive with CRI-coated polystyrene tubes (2054; Falcon Labware, Div. of Becton, Dickinson 
& Co., Oxnard, CA) was measured with protein A (P-9267) conjugated to alkaline phosphatase 
(type VII-S; Sigma Chemical Co.).  Rabbit antiidiotype antibodies to be coupled to alkaline 
phosphatase were further purified from idiotype-specific antisera by affinity chromatography 
on, and chaotropic elution from, a serum idiotype-Sepharose column. 
Two sets of antisera specific for mouse isotypes were used. One was generously supplied by 
Dr. Anne Good, University of California, Berkeley, and the other was purchased from Miles 
Laboratories, Inc., Research Products Div., Elkhart, IN. Other antisera include goat anti-mouse 
K light chain  (21-1079;  Nordic,  London, United Kingdom), rabbit anti-mouse ~. light chain 
(64-367; Miles Laboratories), goat anti-rat IgG (12511; N.L. Cappel Laboratories Inc., Coch- 
ranville, PA), and goat anti-rat isotypes (Pel-Freeze Biologicals, Rogers, AR). 
Mice were immunized variously as described in the text. CFA-induced and anti-ABA-KLH 
hyperimmune ascites were prepared as described by Tung et al. (18). 
Preparation of Ig Chains and Fragments.  Fab fragments were prepared from IgG by digestion 
with  papain  (Sigma Chemical  Co.)  for  5  h  at  37°C  (21).  Fab  fragments  were  purified  by 
gradient elution from DEAE cellulose by using a  2.5-100 mM phosphate gradient at pH 8.0. 
The fragments were sized by gel filtration on Sephadex G-100 and passed  over a  protein A 
Sepharose  CL-4B  column at  pH 8.5  to remove residual Fc fragments and IgG. Analysis by 
gradient sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis (PAGE) and immu- 
noelectrophoresis revealed only Fab fragments. Heavy (H)  and light (L) chains from normal 
A/J  IgG  and  serum  idiotype  were  prepared  by  reduction  with  0.02  M  dithiothreitol  and 
alkylation with 0.12 M  iodoacetimide in N2 (22).  The H  and L chains were separated in 1 M 
acetic acid by chromatography on Sephadex G-100 at 4°C. Serum idiotype and nIgG controls 
were similarly processed, but without reduction and alkylation. The separated chains and the 
Ig were  dialysed vs.  phosphate-buffered saline (PBS), centrifuged at  15,000 rpm  for 30 min, 
and the protein concentrations of the supernatants were determined from their optical densities. 
The molecular weights of the various species were determined on gradient SDS-PAGE. The H 
chains were mixed in all combinations with the L chains so that the final H/L optical density 
ratio was 2.2:1.0. H-L recombination was promoted by dialysing (a) 6 h  vs. 0.5 M  acetic acid 
at room temperature, (b) 24 h vs. 0.1 M  acetic acid, pH 5.5, at 4°C, (c) 24 h vs. 0.02 M  acetic 
acid, pH 5.5, at 4°C, and (d)  24 h  vs. BBS. 
Idiotype and Antibody Assays.  An ELISA (Engvall and Perlman [23])  was adapted to 96-well 
polystyrene microtiter plates so that  an optical  reader  (Flow Laboratories, Inc., Irvine, CA) 
could be used to  measure the extent of reaction. Microtest  plates  (Cooke type R,  M220-29; 
Cooke Engineering Co., Alexandria, VA or Dynatecb Immulon II, Dynatech Laboratories, Inc., 
Alexandria, VA) were coated with 90 #1 of the relevant ligand for 5 h at 37°C or overnight at 
ambient temperature. The ligands, which were dissolved in BBS with 0.04% NAN2, included 
10 #g m1-1 ABA-HSA, or  1.5-2.5 #g m1-1 of (a)  serum idiotype or  Fab  fragments of serum 
idiotype, (b) normal A/J IgG or its Fab fragments, or (c) hydridoma proteins R16.7 or 36-65. 
Before use, the wells were filled for a  minimum of 30 min at room temperature with TBBD 
(BBS containing 1% BSA, 0.02% Tween-20 [P-137; Sigma Chemical Co.], and 1 mg/ml dextran 
sulfate). 95 #l of antibody solution or antibody-enzyme conjugate, which was premixed for 30 
min with dilutions of various inhibitors when appropriate, was added in duplicate to the coated 
plates and allowed to react overnight at ambient temperature. Occasionally, this incubation 
was shortened to 5 h  at 37*C. The wells were then rinsed by washing three times with H20, 
incubating for a  minimum of  10 min with  BBS-0.02% Tween-20, and washing again three 
times with H20. When an additional developing reagent was required, 100 p~l of the appropriate 
alkaline  phosphatase-conjugated  anti-Ig was  diluted  in  TBBD,  added  to  the  plates,  and 
incubated for 5 h at 37°C. The wells were then rinsed as above, and 100 ~1 of the substrate p- 
nitrophenyl-phosphate (104-0; Sigma Chemical Co.) at  1 nag ml  -~ in 0.05 M  Na2CO3, pH 9.6 
was added. The plates were usually incubated at 37°C until the positive control wells had an 
OD40s  >0.5.  The  data  were  analyzed on  a  Hewlett-Packard  model  85  computer  (Hewlett- 
Packard Co., Palo Alto, CA) using programs generated in our laboratory. Anti-Ig antibodies, 
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5 Ci, and rabbit  anti-mouse x and X L  chains, were conjugated to alkaline phosphatase  using 
the method described by Engvall and Perlmann  (23). 
The standard  inhibition  assay  for CRI  ADs used  idiotype-coated plates,  200  ng ml  -a  AD8 
incubated with serial dilutions of sera or hybridoma  proteins to be assayed for idiotype, and 
goat anti-rat Ig alkaline phosphate conjugates. An alternate assay for CRI  ADS substituted ADS- 
biotin for ADS and was developed with 1:300 dilutions of avidin-alkaline phosphatase (A-2100; 
Vector Laboratories, Inc. Burlingame, CA). These two assays, when compared with a  battery 
of eight monoclonal proteins, produced identical patterns of reactivity. The antiidiotypic probes 
in the CRI  a and CRI  ADs assays were, respectively, rabbit antiserum idiotype-alkaline phospha- 
tase  and  5  Ci-alkaline  phosphatase.  The  idiotype  content  was  determined  from  the  linear 
regression of the linear portion  of the inhibition curves,  and  is reported  as  either the serum 
dilution or the protein concentration giving 50% of the maximum OD405 value. 
Anti-arsonate  antibody  was  measured  by  incubating  duplicate  dilutions of sera  on ABA- 
HSA-coated plates  followed by rabbit  anti-mouse K and )k conjugates. The specificity of this 
reaction  was investigated by including a  3-mM concentration  of the hapten  4-azo-his in the 
reaction mix, a concentration that completely inhibited specific interactions. Anti-ABA content 
was determined by interpolating the reactivity of the experimental dilutions onto the curve of 
a  reference  anti-ABA  serum  with  a  known  anti-arsonate  titer.  The  concentration  of anti- 
arsonate antibodies in our standard  antiserum was established using the quantitative precipi- 
tation  assay  and  serial  dilutions  of ABA-BSA.  Isotypes  were  determined  by  Ouchterlony 
analysis  and  relative concentrations  of isotypes  were assayed  using radial  immunodiffusion 
(RID). 
Hybridomas.  The characteristics of the hybridomas used in this study are outlined in Table 
I. Clones AD8 and BA6 were derived from male Lewis rats immunized intraperitioneally with 
500/~g serum idiotype in 0.2 ml CFA, and boosted  10 d  later with  500/lg serum  idiotype in 
IFA. 3 wk later, the rats were boosted on four consecutive days with 300 #g serum idiotype in 
PBS.  These  boosts  were  given  intraperitoneally,  except  for  the  second  boost,  which  was 
administered  intravenously. The spleen was removed on the day following the last boost, and 
the  spleen  cells were  hybridized  with  the  Y3-Ag  1.2.3  rat  myeloma cell  line  (24)  using  the 
5  protocol of Oi and Herzenberg (19), except that  the cells were initially plated at 5 x  10  total 
cells per well in Microtest II plates  (Dynatech  Laboratories,  Inc.). Supernatants  were charac- 
terized using ELISA. Rat  hybridomas  were expanded  in vitro before intraperitoneal  transfer 
into nude mice that  had been primed with 0.5 rnl of pristane on two occasions 7 d  apart  and 
at least  7 d  before tumor transfer. 
Mouse hybridomas were produced by fusing cells from immune A/J mice with the NS1 or 
SP2  cell  lines  using  either  the  method  of Oi  and  Herzenberg  (19)  or of de  St.  Groth  and 
Scheidegger (25). Hybridomas were grown either as ascites in pristane-primed CAF1 mice or in 
TABLE  I 
Hybridoma Characteristics 
Cell line*  Myeloma  ×  Fusion  Antigen  Idi- 
parent  partner  Immunogen  specificity  otype~: Isotype 
ADS  Y3  Lewis rat  Serum idiotype  CRI  ADs  -  IgG2~ 
BA6  Y3  Lewis rat  Serum idiotype  Mouse IGFc  -  IgM 
5Ci  NS1  CD rat  Serum idiotype  CRI  ~ci  -  IgG2a 
5H5  SP2  A/J mouse  ADS  ?  +  IgG~ 
3D10  SP2  A/J mouse  5Ci  ?  +  IgGa 
31C3  NS1  A/J mouse  ABA-KLH  ABA  -  IgG1 
36-65  SP2  A/J mouse  ABA-KLH  ABA  +  IgGi 
R-16.7  SP2  A/J mouse  ABA-KLH  ABA  +  IgG1 
AB2-37.2  SP2  A/J mouse  ABA-Brucella  ABA  +  IgG1 
* 5Ci  and  3D10  were gifts  from L.  Wysocki;  36-65, from  A.  Marshak-Rothstein;  and  R-16.7,  from E. 
Lamoyi. 
:~ Hybridoma proteins that contain any of the CRI associated  with the strain-A anti-arsonate  response, 
including CRP, CRI  ADs, and CRI  sci. See Fig. 2 and Results. 1120  IDIOTYPE CONNECTANCE  IN THE IMMUNE SYSTEM 
vitro using standard conditions. Arsonate-specific antibodies were isolated using affinity chro- 
matography on ABA-tyraminyl-Sepharose. 5H5 was grown in serum-free medium (50% F-12, 
50% RPMI, 10/~g m1-1 transferrin,  10/~g ml -I human insulin, 2 mM glutamine, and 5 ×  10  -5 
M  2-mercaptoethanol),  and  was  isolated  on  protein  A-Sepharose  columns.  Proteins  and 
hybridomas generously supplied  by other investigators  include 5 Ci and  3D10  (L.  Wysocki, 
Harvard  University,  Cambridge,  MA  [7]),  36-65  (Ann  Marshak-Rothstein,  Massachusetts 
Institute of Technology, Cambridge, MA [26]), and  R16.7  (E.  Lamoyi, Brandeis University, 
Waltham, MA [27]). 
Results 
Summa~"  of  Preliminary  Observations.  A  number  of  rat  X  rat  hybridomas  were 
produced  that  reacted  with  serum  idiotype.  Of  this  number,  the  antibody  from 
hybridoma AD8 was  found to be exceptionally  reactive with monovalent  Fab  frag- 
ments  of serum  idiotype.  In  the  studies  that  follow,  AD8  and  5Ci  refer  to  the 
monoclonal  antiidiotypic  hybridoma  antibodies,  CRI  ADs  and  CRI  sci  refer  to  the 
antibodies containing the cognate idiotopes, and CRI" collectively refers to idiotopes 
recognized by our affinity-purified rabbit antiidiotypic probe. In the initial  screen, it 
was found that  i0/~g/ml of serum idiotype or its Fab fragments completely inhibited 
the binding of AD8 to serum idiotype Fab-coated plates,  whereas similar concentra- 
tions of Fab  fragments  from normal  IgG failed to inhibit.  Fortuitously,  this concen- 
tration  of normal  Fab  fragments  was just  below  that  which  reveals  endogenous 
CRI  AD8. For  this  reason,  we  initially  failed  to  detect  CRI  ADs  in  normal  Ig.  The 
presence  of ~9  /lg/ml  CRI  ADs  in  normal  sera  and  CFA-induced  ascites  will  be 
documented below. Further preliminary studies showed that the interaction between 
AD8 and serum idiotype Fab-coated plates could not be inhibited by the CRI- ABA  + 
hybridoma protein from clone 31C3. Additionally, it was shown that several different 
rabbit anti-CRI" antisera would compete with AD8 for binding to serum idiotype. To 
determine if CRI  A~8 is enriched in antibodies specific for ABA, A/J antisera to ABA- 
KLH  and ABA-CGG were extensively depleted  of anti-arsonate  activity by passage 
through ABA-BSA-Sepharose columns. The CRI  At)8 titers of these ABA-depleted sera 
were reduced ~200-fold, indicating that most of the CRI  ADs moieties in ABA-immune 
sera co-purify with  the  anti-arsonate  activity.  Immunochemical and electrophoretic 
analyses showed that ADS was a  rat IgG2b protein. Because these preliminary studies 
demonstrated  that AD8 was indeed antiidiotypic and seemed to have a  high affinity 
for its cognate idiotope, we selected this protein for further study. 
Strain Distribution of CRI  ADs is Similar to that of CRI a.  VH loci that are linked to the 
Igh-C  e  haplotype,  or  to  the  related  Igh-C °  haplotype,  encode  for  a  cross-reactive 
idiotype  (CRI  a,  above)  that  is  expressed  on  a  substantial  fraction  of anti-arsonate 
antibodies  (28). Additionally, most idiotopes of this major cross-reactive idiotype can 
be found on single hybridoma proteins  (26, 27, 29). 
In  light  of the  above  findings,  expression  of CRI  ADs was  examined  during  anti- 
ABA-KLH  responses  in  nine  strains  of mice.  As  shown  in  Table  II,  only  mice 
possessing A-strain  VH genes produced CRI  ADs during this  response.  In contrast,  no 
CRI  ADs was found in mice lacking A-strain VH genes.  Regardless  of their ability  to 
make CRI  ADs, all strains of mice produced similar amounts of anti-arsonate antibodies. 
These results show that the strain distribution of CRI  ADs closely parallels that ofCRI a 
(28). 
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TABLE  II 
ldiotype and Anti-Arsonate Antibody Content in Antisera to ABA-KLH from 
Nine Strains of Mice* 
Strain  Igh-C  n  CRIADS'~:  Anti-ABA,§ 
type  50% Dilution  #g equivalent m1-1 
C.AL/20  o  7  519 (1.89)  97 (2.07) 
CAF1  a/e  6  1,820 (1.48)  337 (2.10) 
A/J  e  8  2,677 (2.39)  367 (2.92) 
DBA/2  c  6  None  ND 
BALB/C  a  6  None  480 
CBA/J  j  6  None  740 
C57B1/6  b  8  None  220 
NZB  n  8  None  590 
C3H/He  j  6  None  440 
* Mice  were  primed  with  150  #g  ABA-KLH  GFA  intraperitoneally,  and 
boosted 3 wk later with 150 #g ABA-KLH/IFA i.p. Antisera were collected 
11 d after boosting. 
~: CRI  ^Ds levels determined using a standard ELISA, in which the binding of 
ADS (200 ng ml  -t) to microtiter plates coated with 1.5 #g m1-1 of serum CRI 
was inhibited by duplicate serial dilutions of each antiserum, and the amount 
of bound ADS was measured using goat anti-rat Ig enzyme conjugates.  The 
level of idiotype is reported as the serum dilution that inhibits 50% of the 
maximum  OD4o5 value.  No  CRI  ADs was  observed in  non-A strain  mice. 
Results are expressed  as geometrical means, with geometrical deviations in 
parentheses. 
§ Antibody equivalents of anti-arsonate Ig were determined with a standard 
ELISA in which microtiter plates were coated with  10 #g ABA-HSA ml  -a, 
incubated with  1:500 antisera dilutions, and developed using anti-mouse K 
and ~. L-chain enzyme conjugates. Antibody equivalents were calculated by 
comparison with the binding curve of a reference anti-ABA-KLH serum pool 
of known  anti-ABA titer. Values followed  by parentheses  are geometrical 
means;  geometrical deviations are in parentheses.  All other values are from 
pooled antisera.  ND, not determined. 
ship of CRI AD6 to the antigen-binding  site was investigated by using ABA haptens to 
compete  the  interaction  between  ADS  and  idiotype-coated  plates.  As  a  specificity 
control, the Fc-specific hybridoma  protein BA6 was similarly assayed. In a  preliminary 
study, neither AD8 nor BA6 were inhibited by concentrations  of phenyl-glu-tyr-ABA 
<5  ×  10  -3 M. Although these results suggested that  the CRI AD6 idiotope is not within 
the arsonate-binding  site, subsequent  studies using hybridoma  protein  R16.7  instead 
of serum idiotype have shown that  the CRI AD6 determinant  is indeed hapten  inhibit- 
able  (Table  III).  Microtiter  plates  were  coated  with  serum  idiotype  or  hybridoma 
proteins  R16.7  or  36-65,  and  the  binding  of AD8  to  these  plates  was  inhibited  by 
dilutions  of various  ABA  haptens.  The  results  using  R16.7-coated  plates  show  that 
binding  was  inhibited  by all haptens  tested.  ABA-tyrosine inhibited  most  efficiently 
(3.9  ×  10  -6 M  at  50%  inhibition)  whereas  ABA-phenyl-propionic  acid  was  the  least 
efficient inhibitor  (7.4  ×  10  -4 M  at 50% inhibition).  However, when the inhibition of 
binding of ADS to 36-65 or serum idiotype was assayed, inhibition was observed only 
at very high hapten  concentrations  (~ 10 -8 M). At least two factors might explain this 
inconsistency:  (a) The affinity of AD8 for 36-65 may be higher than  for R  16.7. Results 
presented  in  Figure  2 B  suggest  that,  indeed,  the  affinity of ADS  for  36-65  is  ~  100- 
fold higher than  for R16.7  (50%  inhibition  of AD8 binding  is 0.11  #g m1-1 for 36-65 
and  11/zg m1-1 for R16.7).  (b) The affinity of R16.7 for ABA may be higher than that 1122  IDIOTYPE  CONNECTANCE IN THE IMMUNE  SYSTEM 
TABLE III 
Hapten Inhibition  of AD8 Binding  to Different  CRI Proteins * 
Hapten 
Plate coated with 
R16.7  36-65  Serum CRI 
ABA-tyrosine  3.9 ×  10 6  8.4 ×  10  -4  >2.5 ×  10  -3 
4-azo-A-his  1.0 ×  I0  -~  >1.3 X 10  -3  >1.3 ×  10 3 
benzyl-glu-tyr-ABA  2.2 X 10  -5  >4 X 10  -a  >4 ×  10  -3 
ABA-phenyl-proprionic  acid  7.4 ×  10  -4  >2.5 X 10  -2  >2.5 X 10  -2 
* Plates were coated with 2 #g m1-1 of idiotypic protein in BBS, and were assayed 
using ELISA as in Table II, with the following modification: AD8 reactivity was 
measured using AD8-biotin, followed by avidin-alkaline phosphatase. The values 
are molar concentrations ofhapten that inhibit 50% of the idiotype-binding  activity. 
of 36-65.  Recent experiments indicate that  R16.7  has  a  4.4-fold higher affinity for 
ABA-tyrosine than does 36-65 (Ks of R16.7 =  1.1  X  106 LM  -1 [30]; Ka of 36-65 =  2.5 
X  l0  s LM -1 IT. Rothstein, personal communication]). 
Genetic studies have shown that,  although CRI  a is coded  for by an A  strain VH 
locus, optimal CRI  a expression requires the appropriate L  chain (31). Although data 
presented  in Table I  on  the  strain  distribution of CRI  ADs  are  consistent with  the 
involvement of the H  chain variable region in the expression of CRI  ADs, they do not 
speak to the role of the L  chain in CRI  aDs expression. The relative roles of both H 
and L  chains in the formation of the idiotope CRI  ADs was investigated by separating 
H  and  L  chains  from  both  serum  idiotype  and  normal  A/J  IgG.  Each  H  chain 
preparation was  reeombined with  one  or  the  other  L  chains.  These  recombinant 
mixtures and the separated chains were assayed in the standard competition ELISA 
using  AD8  and  serum  idiotype  Fab-coated  plates.  Because  our  chain-separation 
protocol does not yield pure H  chains, the role of the L  chain in CRI  ads expression 
must be inferred by comparing the relative effectiveness of the idiotype L  chain vs. 
the normal L chain in restoring the idiotype to a CRI  ADs H  chain preparation. 
This chain-recombination  experiment revealed that the relative amounts of protein 
necessary to restore equivalent idiotypic antigenicity are: idiotype H  and idiotype L, 
1.0;  idiotype H  and normal L,  2.4;  and idiotype H  alone, 3.4. The idiotype L  chain 
alone or combined with the normal H  chain failed to inhibit at concentrations up to 
20 #g m1-1. Endogenous CRI  ADs occurs at  1 part in 1,000 in normal Ig and was below 
the range needed to influence our chain-recombination  experiments. This experiment 
suggests  that,  although the  AD8  idiotope is a  an  H  chain-associated structure, the 
correct  L  chain is required for optimal expression. These findings are similar to the 
genetic and sequence studies in the CRI  a system (31, 32). 
CRI  ADs is Found in Normal Serum.  In a  series of control experiments we found that 
high concentrations of normal A/J  IgG inhibited in our CRI  ADs  assays, suggesting 
that CRI  ADs might also be found in normal A/J serum. To test this hypothesis, sera 
from 11 nonimmunized  A/J mice were analyzed individually  for CRI  ADs and for anti- 
ABA activity. These values are compared with those of an ascites pool from A/J mice 
hyperimmune to  ABA-KLH  in Table IV.  The  average CRI  ADs content in normal 
serum was  estimated to  be  9.4 /~g  ml  -t  (range, 2.7-16.3 /~g ml-1).  By contrast, the 
hyperimmune ascites pool  contained 2,400/Lg m1-1 of the CRI  ADs+ molecules. The 
CRI  ADs in normal serum is probably not associated with an ABA-binding  Ig because PETER V.  HORNBECK  AND GEORGE  K.  LEWIS  1123 
TABLE IV 
Idiotype and Anti-Arsonate Content of Normal A /J Sera Compared  with an 
Ascites Pool  from A/J Mice Hyperimmune to ABA-KLH * 
Antibody equivalents, #g m1-1 
n 
cRIAD8~  Anti-ABA§ 
Normal sera  11  9.4 (1.83)  0 (P < 0.1370) 
Hyperimmune ascites  --  2,400  9,700 
* Hyperimmune ascites prepared as in (18). 
:]: Determinations for normal sera as in Table II. Antibody equivalents were 
estimated by comparison of the inhibition curves of each normal serum with 
the  inhibition  curve  of the  hyperimmune  pool. CRI  ADs content  of the 
hyperimmune pool was determined by measuring the amount of antibody 
that was affinity purified on an AD8-Sepharose column. Normal sera value 
is expressed as the geometrical mean, followed parenthetically by geometrical 
deviation. 
§ Anti-ABA values of normal sera were determined using ELISA in which sera 
were diluted 1:20, either with or without 3 mM 4-azo-his, incubated 3 h at 
21°C, added to the plates, and processed in the standard fashion (Table II). 
Control anti-ABA serum dilutions were completely inhibited by this proce- 
dure, but no specific binding of antibodies from normal sera to ABA was 
observed (P < 0.1370). The anti-ABA content of the hyperimmune pool was 
determined in a quantitative precipitin assay. 
we failed to detect anti-ABA Ig in the serum with an assay sensitive to  10-100 ng Ig 
m1-1 and also because the CRI  ADs in CFA-induced ascites is not removed by passage 
through an ABA-affinity column. This result is similar to that of Wysocki and Sato 
(7)  for the CRI  a system and to that of Dzierzak and Janeway (8)  for the MOPC-460 
system. 
IgG Isotypes Associated with CRI  ads on Arsonate-binding  Serum Antibodies Differ  from Those 
on Arsonate-nonbinding  Serum Antibodies.  Initial studies of isotype distribution of ABA  + 
CRI  a serum antibodies isolated from  ABA-KLH ascites indicated that  most of the 
idiotype was found on the IgG1  (33)  subclass. Subsequent investigations using both 
hybridoma technology (26,  27)  and conventional immunization schemes  (34)  have 
shown that CRI" can be expressed on most subclasses. Because the isotype of a  given 
antibody population may  reveal  clues  about  both  the  biological function of that 
population  and  the  nature  of  its  cognate  antigen  (i.e.,  TD,  TI1,  TI2  [35]),  we 
determined  the  isotypes  of ABA-  CRI  AD8+ antibodies  found  in  normal  sera  and 
compared  them  with  the  isotypic profile of anti-arsonate antibodies isolated  from 
hyperimmune anti-ABA-KLH ascites. 
The experiment shown in Table V  was designed to reveal IgG subclass restrictions 
of CRI  ADs in anti-arsonate IgG and in normal IgG. ABA  + IgG was affinity purified 
on ABA-tyramine-Sepharose-4b  from ascites induced by ABA-KLH in CFA, whereas 
normal IgG was purified from aseites induced by CFA alone. This choice was dictated 
by the need for a  CFA control to compare with ABA-KLH/CFA-induced  ascites and 
by the need for relatively large volumes of normal A/J serum to do the experiment. 
Additional experiments have  shown  that  CRI  ~°8  levels in  normal sera  and  CFA- 
induced ascites fluid are indistinguishable. Nevertheless, we emphasize that we cannot 
presently rule out the possibility that CFA priming during ascites production alters 
the  subclass distribution of CRI  Ax)s. Although no  anti-ABA activity was  found in 
either CFA ascites or normal sera,  the CFA ascites was extensively absorbed on an 1124  IDIOTYPE  CONNECTANCE IN THE  IMMUNE SYSTEM 
TABLE  V 
Isotype Associations  of CRI  aria in A /J Anti-Arsonate  Antibodies  Compared with 
Normal ABA- A/J Antibodies 
Elution*  IgG isotypes:~  Anti-ABA Ig§  Normal Igll 
pH  1  2a  2b  3  lgG  CRI  ADs**  CRIADS/IgG  IgG¶  CRI  ADs**  CRIADS/IgG 
%  %  %  % 
8.6  1.4  0.0  0.1  0.0  40  39  1.0  37  <8  <0.2 
5.5  0.2  2.0  0.6  0.2  43  44  1.0  4t  51  1.2 
4.5  0.0  1.0  0.6  4.2  10  12  1.2  18  41  2.3 
Total percent  93  95  96  100 
Percent of total IgG containing  24  0. t 
CRI  ADs 
* Elution pH from Staphylococcus aureus protein A-Sepharose  columns. 
.~ Relative enrichment of four IgG isotypes eluted from protein A columns.  Isotype concentrations were 
measured using RID and two sets of subclass-specific antisera from different sources. Relative enrichment 
at each pH is expressed as the ratio of the amount of isotype in each fraction of IgG over the amount of 
isotype in unfractionated normal A/J IgG. 
§ Anti-arsonate Ig was affinity purified from pooled ascites fluid from A/J mice hyperimmune to ABA- 
KLH on an ABA-tyraminyl-affigel column and chaotropically eluted. 
II Normal A/J IgG was isolated from pooled ascites fluid induced by multiple intraperitoneal injections of 
0.3 ml CFA/PBS (9:1) emulsion.  Ascites fluid was run through an ABA-BSA column before isolation of 
the IgG by Na~SO4 precipitation, DEAE fractionation, and gel chromatography. 
¶ Percent of total IgG that was  purified at each pH.  Protein content was determined using OD2s0 and 
~g/~l =  1.4. 
** Percent of total CRI  ADs that was purified at each pH. CRI  ADs content was determined using ELISA as 
in Table II. 
ABA-BSA-Sepharose  to  remove  any  possible  anti-arsonate  antibody  before  IgG 
purification.  No anti-ABA antibody could be eluted.  The two IgG preparations  were 
each  fractionated  into  subclasses  by  differential  pH  elution  from  staplylococcus 
protein A-Sepharose. The efficiency of the protein A  fractionation step was monitored 
by  RID  by using  two sets of subclass-specific antisera  from different sources.  Signifi- 
cant  amounts  of antibody  were  eluted  at  three  pH  values:  8.6,  5.5,  and  4.5.  These 
three  fractions  accounted  for  93%  of the  total  anti-ABA  antibody  adsorbed  to  the 
column  and  for 96%  of the  normal  Ig.  Insignificant  amounts  of protein  desorbed  at 
pH  7.0  (data  not  shown).  Neither IgM nor IgA detectable  by RID  was  found  in any 
of the  three  fractions.  The  values of the different  subclasses  relative to  the  values of 
normal  IgG before fractionation  are shown  for each elution pH.  The pH  8.6 fraction 
was  enriched  1.4-fold  for IgG1  and  depleted  10-fold  of IgG2b,  whereas  neither  IgGz~ 
nor IgG3 was detected in this pH  fraction. The  pH  5.5  fraction was enriched  twofold 
for IgG2a, contained significant levels of IgG2u (0.6  ×  normal levels), and was depleted 
fivefold  of  IgG1  and  IgG3.  The  pH  4.5  fraction  was  enriched  fourfold  for  IgGa, 
contained  significant  levels  of IgGza  and  IgGzb  (1.0  and  0.6,  respectively)  and  was 
virtually  depleted  of IgG1.  Although  the  subclass  fractionation  was  not  absolute,  it 
was sufficient to differentiate  IgG1 from IgGz and  IgG3. 
The  percentage  of total  IgG  purified  at  each  pH  for  both  Ig  preparations  was 
calculated  and  compared  with  the percentage  of idiotype contained  in  the same pH PETER  V.  HORNBECK  AND GEORGE  K.  LEWIS  1125 
fractions. A  striking difference was observed in the isotype association of CRI  ADs in 
ABA  ÷  IgG compared  with  CRI n°a  in  ABA-  IgG.  For anti-ABA IgG, CRI  ADs was 
uniformly distributed across all three pH  fractions  (CRIADS/IgG ratios from  1.0  to 
1.2). However, a  quite different pattern was observed in the ABA- IgG: the IgGl-rich 
(pH 8.6)  fraction was depleted 80% of CRI  ADs, whereas the IgG3-IgG2a-rich (pH 4.5) 
fraction  was  enriched  230%  for  CRI  ~s.  This  suggests  that  the  CRI  ~x~s found  in 
normal  IgG  is  preferentially  associated  with  the  IgG3  and  IgGz  subclasses.  This 
subclass distribution is similar to that  seen in TI-1  antibody responses  (35).  On  the 
other hand, after immunization with ABA-KLH, a strong thymus-dependent antigen, 
CRI  ~Ds, is expressed as frequently on IgG1 as on the other subclasses. The bottom row 
of Table V  lists the percentage  of total IgG that  contains CRI  ADs, and  shows  that 
CRI  Arts is enriched >200-fold  in  the  ABA-specific antibody preparation compared 
with the normal Ig preparation. 
CRI  ADs is Found on at Least 80% of the Molecules  Expressing CRI a in ABA-KLH-induced 
Ascites.  Because the expression of CRI ADs closely parallels that  of CRI a  (Table II) 
(28), it was important to determine the degree of association between the two idiotypes 
in  ABA-KLH  hyperimmune  ascites.  For this experiment,  hyperimmune  anti-ABA- 
KLH  ascites  fluid  was  absorbed  with  either  AD8-Sepharose  4B  or  normal  rat  Ig- 
Sepharose 4B.  After absorption, the amounts of CRI  ADs and CRI" remaining in the 
filtrate were determined. The results of this experiment are shown in Fig. 1. Absorption 
on AD8-Sepharose removed >99%  (Fig.  1 A) of the CRI ADs and  ~80%  (Fig.  1 B)  of 
the  CRI a  from  the  hyperimmune  anti-ABA-KLH  ascites.  On  the  other  hand,  the 
control  normal  rat  Ig immunoadsorbant  did  not  significantly remove  any  CRI  ADs 
from the preparation. Additional assays (not shown)  indicated that >99% of CRI  5el 
was  removed  by absorption  on  ADS-Sepharose. This  experiment  shows  that,  in  an 
idiotype-rich anti-ABA-KLH ascites fluid, CRI  ADs and  CRI a  are expressed on  the 
same molecules at least 80% of the time. Under these conditions, CRI 5ci is practically 
always coexpressed on molecules containing the CRI A°8 marker. 
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Fin.  1.  Anti-ABA-KLH ascites fluid from A/J mice, passed through an AD8 immunoabsorbent, 
was analysed for CRI  ADs content  (A) and for CRI" content  (B). Whole ascites fluid (0); passed 
through AD8-Sepharose (O); and passed through normal rat IgG-Sepharose (,Ix,).  CRI  ADs levels were 
measured with an ELISA in which the inhibition of the binding of AD8 to serum CRI-coated plates 
was measured with a goat anti-rat IgG enzyme probe; CRI =  was measured by inhibiting the binding 
of rabbit anti-CRI-alkaline  phosphatase conjugates. 1126  IDIOTYPE  CONNECTANCE  IN  THE  IMMUNE  SYSTEM 
CRI  Aos Can Be Expressed on A /J Hybridoma  Proteins Independently  of Either CRI  a or Anti- 
ABA  Reactivity.  The  apparent  expression  of CRI  ADs  on  ABA-  normal  mouse  Ig 
contrasts with the finding that most of the CRI  ADs in ABA-immune sera is associated 
with  arsonate-binding  molecules  (see  Summary  of  Preliminary  Observations, 
above). These results suggest that  CRI  ADs is a  new major CRI related to the CRI a 
family and,  paradoxically,  that  the expression of this  idiotope is  not  diagnostic  for 
anti-ABA activity. 
To further characterize the relationships between CRI  ADs, CRI a, CR[  5ci, and anti- 
ABA activity, we compared four CRI "+ hybridoma proteins  (Fig.  2).  We modified 
the ELISA for idiotype by coating microtiter plates with hybridoma protein  R16.7 
instead of serum idiotype, and by inhibiting two additional antiidiotype preparations, 
rabbit anti-CRI" and 5Ci. Two of the proteins studied, 36-65 (26) and R16.7 (27), are 
prototypic ABA  + CRI a+ Ig that contain most, if not all, of the idiotypic determinants 
expressed on  A/J  CRI "+  antibodies.  When  compared with  one  another  using  the 
rabbit anti-CRI  a probe (Fig. 2A), both 36-65 and R16.7 were excellent inhibitors. On 
the other hand, the ABA- proteins 5H5 and 3D10 were 100- and 200-fold less effective 
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FIe.  2.  Comparison of the idiotypic composition of four different CRI + hybridoma proteins using 
three different antiidiotypic probes: rabbit anti-CRP (A), AD8 (B), and 5Ci  (C). Microtiter plates 
were coated with  2 #g protein  R16.7  m1-1, constant concentrations of the antiidiotypic  reagents 
were inhibited by dilutions of purified hybridoma proteins, and the amount of antiidiotype bound 
to the plates was determined using ELISA. The inhibitors include proteins 36-65  (A), R16.7  ((D), 
5H5 (O), and 3D10 (A). PETER V.  HORNBECK AND GEORGE K.  LEWIS  1127 
than 36-65 in inhibiting rabbit anti-CRI a, respectively. This same order of reactivity 
was observed when serum idiotype rather than R16.7 was used on the solid phase. 
When the four proteins were compared for CRI  ADs expression  (Fig.  2 B),  quite a 
different pattern emerged. The ABA-  protein 5H5, which was one of the least effective 
inhibitors of rabbit anti-CRI", was the most effective inhibitor of ADS. Surprisingly, 
R16.7  was  85-fold  less  effective an  inhibitor  than  36-65,  suggesting that  the  AD8 
idiotope  is  less  fully expressed  on  R16.7  than  on  36-65  or  5H5.  These  two sets  of 
observations  demonstrate  that  CRI  ADs  expression  can  occur independently  of the 
expression of either CRI  a or arsonate binding.  Complete dissociation of CRI"  from 
CRI  ADs was seen with  protein AB2-37.2, which strongly expresses  CRI ~ but  which 
lacks CRI  ~°s  (data not shown). The independence of arsonate binding and CRI  ADs 
is further underscored by the ABA- protein 3D10, which expresses CRI  ADs with an 
antigenicity intermediate  in effectiveness between  proteins  36-65  and  R16.7.  Thus, 
CRI  A°8, like CRI  a (7), can be expressed on ABA- antibodies. Furthermore, all ABA-, 
idiotype-positive  proteins  that  we  have  examined  seem  to  express  CRI  A°s  more 
effectively than they do CRI". 
Because  the  relative  inhibition  profiles  of these  four hybridoma proteins  varied 
widely  between  the  rabbit  anti-CRI a  and  the  AD8  probes  (Figs.  2A  and  B),  we 
repeated the experiment using protein 5Ci, another monoclonal antiidiotype derived 
by Wysocki and Sato (Fig.  2C) (7). The ABA- protein 3D10 as well as two prototypic 
proteins,  36-65  and  R16.7,  expressed  CRI  5el  very efficiently,  whereas  protein  5H5 
completely lacks tlais idiotope. 
Selective  Stimulation  of the ABA-  Subpopulation  of CRI  ADs Correlates with Limited Respon- 
siveness  of the ABA + Subpopulation  of CRI  sos to ABA-KLH.  In the previous sections, it 
was shown that although CRI  ADs expression could be dissociated from the expression 
of CRI a, CRI  5ci, and ABA binding, immunization with ABA-KLH regularly elicits 
antibodies having all of these markers. In this section, we will show that it is possible 
to selectively stimulate  the ABA- CRI  ADs+ set  and that  such stimulation correlates 
with limited responsiveness of the ABA  + CRI  ADs÷ set to ABA-KLH. 
Selective immunization of the ABA- subpopulation of CRI  A°8 is shown in Table 
VI. On the basis of preliminary dose-response experiments using both normal rat IgG 
and ADS in the range of 1 ng to  100 #g per mouse, a  dose of 40 #g per mouse was 
selected for this experiment. This dose was chosen because it stimulated the production 
of ABA- CRI  ADs+ antibodies while causing only a  marginal increase in anti-rat IgG 
antibodies. Artifactual inhibition of the CRI  ADs assay by mouse anti-rat IgG antibod- 
ies was prevented by modifying the ELISA as follows: antiserum dilutions from AD8- 
or normal rat IgG-immunized animals were mixed with  100/~g m1-1 normal rat IgG 
and  incubated  20  min  at  37°C;  an  equal  volume of this  mixture  was added  to a 
solution of 200 ng/ml AD8 and  incubated  for 30 min;  this  solution was added  to 
idiotype-coated plates and assayed for the inhibition of AD8 binding as described in 
Materials and Methods. In control experiments, this modification removed nonspecific 
inhibition of the CRI  ADs assay produced by a standard mouse anti-rat IgG antiserum 
but did not reduce the apparent  CRI  ADs content of antisera from mice immunized 
with  ADS.  Specificity of this  system  for CRI  ~ags was  further established  in  a  large 
series  of experiments (c.f., Tables VII and VIII) in which normal rat IgG was used as 
an immunization control for ADS. In none of these experiments did normal rat IgG 1128  IDIOTYPE  CONNECTANCE  IN  THE  IMMUNE  SYSTEM 
TABLE  VI 
Immunization with Antiidiotope  AD8 Compared with Immumzation with ABA-KLH:  Differential Effects 
upon the Induction  of ldiotype  and Anti-Arsonate Antibodies  in A/J Sera 
CRIA°S,~:  CRI ",§  CRi~Ci,i  I  Anti-ABA,¶ 
n  /Lg equivalent  Group  Treatment*  50% Dilution  50% Dilution  50% Dilution  ml_l 
A  --  5  132 (1.30)  37  (1.31)  <10  0 
B  40/.tg AD8  5  740  (1.26)  51  (1.81)  <10  0 
C  40/.tg AD8, 3 x  5  616 (1.66)  89 (!.49)  <10  2.3  (1.44) 
D  40/~g ABA-KLH, 3 x  5  616 (1.44)  776 (2.24)  47 (1.42)  25.1  (1.87) 
* Immunogen injected intraperitoneally in PBS. Groups C and D received three doses at 3-d intervals. Sera 
were collected on day 7 after last immunization. 
:~ Determined as in Table II, except that  plates were coated with R16.7  instead of serum idiotype. The 
antiidiotypic nature of the response was confirmed by including  100 #g ml -] of normal rat  IgG in the 
incubation mix to inhibit nonidiotypic interactions. 
§ Determined by ELISA, in which microtiter plates were coated with R16.7  and the antiidiotypic probe 
was rabbit antiidiotype alkaline phosphatase conjugates. CRI" levels in group B were not significantly 
elevated when compared with group A  (P <  0.1501),  whereas both group C  and D  were significantly 
elevated  (P <  0.0018  and  P  <  0.0001,  respectively).  Geometrical  mean  is  followed  by  geometrical 
deviation. 
][ Determined by ELISA, in which plates were coated with R 16.7 and probed with 5Ci-alkaline phosphatase 
conjugates. Only group D showed a significant increase (P <  0.0238)  in CRI  5ei titer. 
¶ Determined using ELISA as in Table II. Geometrical mean is followed parenthetically by geometrical 
deviation. 
TABLE  VII 
Comparison of the Idiotype  Levels and Anti-ABA  Activity in A/J Antisera  to ABA-KLH in Mice 
Pretreated with AD8 or Normal Rat Ig* 
Antiserum dilution at 50% inhibition:~  Anti-ABA,§/~g 
Group  n  Pretreatment 
CRIADS  CRiabt  CRiSCi  equivalent ml 
A  5  20/Lg normal rat Ig  13,600  (2.60)  102,000  (1.65)  81,300 (11.4)  135 (2.93) 
B  5  20/~g AD8  2,300 (4.02)  15,800  (4.29)  832 (2.65)  228 (8.42) 
t test, B vs. A  P <  0.033  P <  0.023  P <  0.006  P <  0.321 
* Mice were pretreated with 20/.tg of AD8 or nRatlg in PBS by intraperitoneal injection. 7 d  later they 
were primed with 150/~g ABA-KLH/CFA i.p. and 3 wk later were boosted with 150/tg ABA-KLH/IFA 
i.p. Antisera were collected 7 d after boosting. 
:~ Antiserum dilutions that inhibit 50% of the binding of three different antiidiotypes in ELISA. Microtiter 
plates were coated with 2/.tg R16.7 m1-1. Constant concentrations of antiidiotypic reagents (AD8, rabbit 
antiserum idiotype-alkaline phosphatase, or 5Ci-alkaline phosphatase) were inhibited by serial dilutions 
ofn different antisera, and the amount of antiidiotype bound to the plates was determined using ELISA. 
§ Determined using ELISA as in Table II. 
elicit an  apparent  increase  in  CRI ADs. For  this reason,  normal  rat  IgG  immunization 
controls  were omitted  from  some  experiments  (c.f., Table  VI). 
In  the  experiment  shown  in  Table  VI,  a  single  40-/zg  dose  of AD8  stimulated  a 
fivefold  increase  in  CRI ADs  titer  compared  with  nonimmunized  mice  (Table  VI, 
group  B  vs.  group  A)  without  any  apparent  increase  in  CRI",  CRI 5ci,  or  anti-ABA 
antibody  activity. This result suggests that  giving a  single 40-/zg dose of AD8  selectively 
stimulates  the  ABA-  CRI ADs+  set.  Repeated  inoculations  of AD8  were  required  to 
increase  the  CRI  a  and  anti-ABA  titers  (Table  VI,  group  C);  however,  in  this  group PETER  V.  HORNBECK AND GEORGE  K.  LEWIS  1129 
TABLE  VIII 
Dose-Response Correlation of the Appearance of CRI  ADs after 
ADS Treatment with the Appearance of ldiotype Suppression Induced by AD8 
followed by ABA-KLH* 
Group  n  Pretreatment 
CRI  ADs, 50% dilution:~ 
Before ABA-  After ABA-KLH[]  KLH§ 
A  6  1.1 /zg AD8  179 (1.69)  21,460 (1.60) 
B  6  3.3 #g AD8  87 (1.53)  13,022 (1.68) 
C  6  10 #g AD8  182 (2.00)  9,651 (2.58) 
D  6  20 #g AD8  993 (1.54)  3,685 (2.51) 
E  6  20/~g nRatIg  100 (1.65)  16,482 (1.74) 
F  6  --  ND  14,981 (1.72) 
* Same protocol as in Table VII, except that the IgG pretreatment doses are 
varied. 
:~ Determined  using  ELISA as  in Table  II, except  plates  were  coated with 
hybridoma  protein  R16.7  instead  of serum  idiotype. Values expressed  as 
geometrical means followed in parentheses  by geometrical deviations. 
§ Sera from animals  that  were bled  7 d  after pretreatment.  Students' t test 
between the nRatIg control group and the AD8 experimental groups  indi- 
cated that a  significant increase  in CRI  ADs content  (P <  0.0001)  occurred 
only in the mice that received 20/zg AD8. 
]] Sera from animals that were immunized with  150/Lg ABA-KLH/CFA 7 d 
after pretreatment, boosted with 150/Lg ABA-KLH/IFA 3 wk later, and bled 
7 d after boost. Significant suppression  in the AD8-treated groups relative to 
the nRatIg control group appeared only in the group pretreated with 20 #g 
AD8 (P <  0.0033). 
the titers of CRI ADs were not  increased  relative to those found  for mice that  received 
a  single 40-#g dose of AD8. Immunization  with ABA-KLH  in PBS caused significant 
increases  in  CRI ~ci  as  well  as  in  CRI",  CRI ADs,  and  anti-ABA  activity.  To  further 
document  the selectivity of low doses of ADS for stimulating  the ABA-  CRI ADs+ set, 
hybridomas  were  made  from  mice  immunized  with  40  /.tg  of  AD8.  None  of  the 
hybridomas  were  ABA  +  or CRI ~ci+.  However,  all  of the  CRI ADs+ hybridomas  were 
cross-reactive in the CRI"  assay  (Fig. 2).  Like the ABA-  CRI ADs+ antibodies found in 
normal sera, the ABA- CRI ADs+ hybridomas were either of the IgG2 or IgG8 subclasses. 
The ABA-  CRI ADs+ hybridomas  2E2 and 5H5 cross-reacted in the CRI a assay, giving 
relatively  shallow  inhibition'  curves  when  compared  with  the  prototypic  CRI a÷ 
hybridomas  36-65  and  R16.7  (Fig.  2,  and  unpublished  observations).  Because  both 
serum  and  hybridoma  ABA-  CRI ADs+ antibodies  give shallow  inhibition  curves  in 
the CRI ~ assay,  it is difficult to detect  less than  threefold changes  in their concentra- 
tions.  It  is possible  that  this  is the reason  we failed to detect  a  significant  increase  in 
CRI ~ when 40 #g of AD8 was used as a  stimulus.  In all of our experiments,  giving 20 
/~g or more of AD8  has resulted  in a  5-10-fold  increase in CRI ADs concentrations. 
Together,  the  data  from  immunizations  with  AD8  contrast  with  the  responses  to 
ABA-protein conjugates.  By using a  single low dose of AD8, it is possible to selectively 
stimulate  the ABA-  CRI ADs+ set.  This subpopulation  is also CRI 5ci- and  is possibly 
cross-reactive  in  the  CRI a  assay.  By  contrast,  immunization  with  ABA-KLH  selec- 
tively stimulates  the ABA  +  CRI ADs+ set  (Table VI and  below)  which  is CRI ~ci+  and 1130  IDIOTYPE  CONNECTANCE  IN  THE  IMMUNE  SYSTEM 
fully cross-reactive in  the CRI" assay.  Because each of the  CRI ADs  subpopulations 
could be selectively immunized, it was possible to determine if stimulating the ABA- 
subpopulation of CRI  ADs affected subsequent responses of the ABA  + subpopulation 
to ABA-KLH. If responsiveness of the ABA  + CRI  ADs+ set remains unaffected by prior 
stimulation of the ABA- CRI  ADs+ set,  it is unlikely that idiotopes such as CRI  ADs are 
used  as  regulatory  idiotopes.  On  the  other  hand,  if responsiveness  of the  ABA  + 
CRI  ADs+ set is affected, it is possible that CRI  ADs correlates with a regulatory idiotope. 
Data presented  in Tables VII and VIII suggest that boosting a  prior response in 
the ABA- CRI  ADs+ set is connected with reduced responsiveness in the ABA  + CRI  ADs+ 
set to ABA-KLH. The experiment shown in Table VII shows that AD8 can induce 
idiotype  suppression  in  the  anti-ABA-KLH response.  A/J  mice  received  20 ttg  of 
either AD8 or normal rat IgG followed by priming and boosting with ABA-KLH. 7 
d  after boosting the mice were bled and their sera assayed for anti-ABA antibodies, 
CRI a, CRI  5ci, and CRI  ADs. All three idiotopes were suppressed (83% for CRI  ADs, 85% 
for CRI", and 99% for CRISCi). Anti-ABA activity remained unchanged. These results 
are similar to those previously reported for idiotype suppression in the CRI a system 
(36, 37).  Like the CRI" system (37), idiotype suppression in the CRI  ADs system can be 
transferred with cells  (unpublished observations), which suggests an active mechanism 
and  rules  out  possible  effects  of residual  AD8  on  the  CRI  ADs  assay.  Along with 
idiotype depletion experiments (see below), this experiment suggests that AD8 priming 
causes a significant reduction in the responsiveness of the ABA  + CRI  ADs+ set to ABA- 
KLH. 
To correlate stimulation of the ABA- CRI  ADs+ set  with reduced responsiveness of 
the  ABA  + CRI  ADs+ set  to ABA-KLH, an  experiment  was performed in  which  the 
dose of AD8 was varied from 1/.tg per mouse to 20/~g per mouse in narrow increments. 
7 d later and immediately before immunization with ABA-KLH, the mice were bled. 
The mice were bled again 7 d after priming and boosting with ABA-KLH, and both 
sets of sera were analyzed for CRI  ADs. The results are shown in Table VIII. Doses of 
10/zg or less of AD8 (groups A, B, and C) failed to reveal either significant stimulation 
of CRI ADs or significant suppression of CRI ADs after immunization with ABA-KLH. 
By contrast, doubling the dose of AD8 to 20/zg per mouse (group D vs. E) stimulated 
an ~ 10-fold increase in CRI  ADs relative to the normal rat IgG control group (before 
immunization  with  ABA-KLH)  and  primed  for  77%  suppression  of CRI  ADs  after 
immunization with ABA-KLH. Limited responsiveness of the ABA  + CRI  ADs+ set was 
verified  by exhaustively  depleting  each  of the  individual  anti-ABA-KLH antisera 
from groups D  and E  on ABA immunosorbents.  Residual CRI  ADs titers for the two 
groups were statistically indistinguishable  (338  (x/+  1.82) for group D  and 324  (x/ 
+  2.10)  for group E). These data show that in mice receiving 20 ttg ADS, the ABA  + 
CRI  ADs+ response to ABA-KLH is reduced by ~80%. Selectivity of ABA-KLH toward 
the ABA  + CRI  ADs+ set was shown by depleting sera from group E, both before and 
after ABA-KLH, on ABA immunosorbents and analyzing for residual CRI  ADs. After 
depletion, the pre-ABA-KLH titer of CRI  ADs was 100 (x/+  1.65) whereas that for the 
post-ABA-KLH  was  324  (x/+  2.10),  which  indicates  that  ABA-KLH  does  not 
significantly stimulate the ABA- CRI  ADs+ set. 
Discussion 
The experimental  results  described  above suggest that  shared idiotypy can func- 
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Furthermore,  these  data  are  consistent  with  the  argument  favoring  a  connection 
between idiotype dominance in induced antihapten responses and the prior occurrence 
of idiotypically related responses directed toward internal or environmental stimuli. 
Our  experiments  were  possible  because  of the  serendipitous  discovery  of a  rat 
monoclonal antiidiotype antibody detecting a new cross-reactive idiotope CRI  ADs. In 
A  strain or related mice, CRI  ADs is found on both induced anti-ABA antibodies and 
naturally occurring antibodies not binding ABA. Furthermore, division of the CRI  ADs 
idiotope family into two dominant subpopulations is supported by the lack of CRI  5ci 
expression  in the naturally occurring ABA- CRI  ADs+ set  in contrast  to the  induced 
ABA  + CRI  ADs+ set that expresses CRI  5el. Each of these CRI  ADs subpopulations could 
be selectively immunized. A single low dose of antiidiotype AD8 selectively stimulated 
the ABA- CRI  ADs+ set.  In contrast,  immunization with ABA-KLH selectively stim- 
ulated  the  ABA  +  CRI  ADs+ set.  Because  the  CRI  ADs subpopulations  could  each  be 
selectively immunized,  it was possible to study the effect of stimulating one subpop- 
ulation on subsequent responsiveness of the reciprocal subpopulation.  If each subpop- 
ulation responds independently of the other after sequential stimuli, it is unlikely that 
sharing of CRI  ADs by the two subpopulations  is biologically important.  If, however, 
shared  idiotypy functionally connects these two responses, stimulating one subpopu- 
lation might modify subsequent  responses of the reciprocal subpopulation.  In princi- 
ple, the experiment could be done by giving either ABA-KLH or AD8 first and then 
immunizing  with  the  reciprocal  stimulus.  We  chose  to  first  give AD8  followed  by 
ABA-KLH because  this  immunization  schedule  has  been  shown  to elicit  idiotype- 
specific suppression  in the CRI a system  (36).  Using this immunization schedule, the 
mice were  bled  before  being  given  ABA-KLH to correlate  responses  in  the  ABA- 
(]RI  nds+ set with  the subsequent  responsiveness  of the ABA  + CRI  ADs+ set  to ABA- 
KLH. These experiments suggest that stimulating the ABA- CRI  ADs+ set dramatically 
limits the subsequent  responsiveness of the ABA  + CRI  ADs+ set to ABA-KLH and that 
CRI  ADs  expression  links  the  ABA-  CRI  ADs+ set  with  the  ABA  +  CRI  ADs+ at  the 
regulatory level. Based on these observations, Jerne's original concept (13) of dissimilar 
immune responses being linked via unspecific parallel  sets appears to he correct. 
The strict interpretation  of our findings should be qualified in two ways. First, the 
data connecting a  response in the ABA- CRI  ADs+ set with reduced responsiveness in 
the  ABA  +  CRI  ADs+ set  were  correlative,  and  as  such,  do  not  establish  causality. 
Second, the selectivity of a single low dose of AD8 toward the ABA- CRI  ADs+ set may 
be more apparent  than real.  Although repeated  innoculations of ADS were required 
to  induce  even  small  ABA  +  responses,  it  is  possible  that  AD8 stimulates  a  cryptic 
response in the ABA  + CRI  ADs+ set which leads  to idiotype suppression  after  immu- 
nization with ABA-KLH. Without  formally overcoming these objections, the experi- 
ment in which the dose of AD8 was varied in narrow dose increments argues against 
these interpretations.  In this experiment,  giving doses of 10/tg or less of AD8 failed to 
either reproducibly stimulate  the ABA- CRI  ADs+ set or to alter the responsiveness of 
the ABA  + CRI  ADs+ set to ABA-KLH. Doubling the dose of AD8 to 20 ~g both boosted 
the ABA- CRI  ADs+ set and  reduced the responsiveness  of the ABA  + CRI  ADs+ set to 
ABA-KLH.  Although  these  data  are  correlative,  the  repeated  appearance  of both 
boosting in the ABA- CRI  ADs+ set and reduced responsiveness of the ABA  + CRI  ADs+ 
set,  at exactly the same dose of ADS, suggests that  the two phenomena are causally 
related.  If a  single low dose of AD8 induces a  cryptic response in the ABA  + CRI  ADs+ 1132  IDIOTYPE CONNECTANCE  IN TIlE  IMMUNE SYSTEM 
subpopulation,  leading to suppression  after immunization with ABA-KLH, it seems 
unlikely that  the dose response for this  putative cryptic response would be the same 
as  that  found  for boosting the  ABA- CRI  ADs+ set.  The importance  of immunizing 
with AD8 is further underscored by other experiments  (data not shown) in which the 
ABA- CRI  sci- CRI  ADs+ hybridoma 5H5 was infused into normal A/J mice to levels 
approximating  those  elicited  by  AD8  before  immunization  with  ABA-KLH.  This 
manipulation  had no effect on the subsequent  responsiveness  of the ABA  ÷ CRI  ADs+ 
set to ABA-KLH despite the similarity of protein 5H5 to the antibodies found in mice 
immunized with AD8 (5H5 was raised by immunization with AD8 before fusion). 
Assuming  that  the  reduced  responsiveness  of the  ABA  +  CRI  ADs+ set  is  due  to 
boosting by AD8 of the ABA- CRI  ADs+ set,  the mechanism  by which this  boosting 
reduces  the  responsiveness  of  the  ABA  +  CRI  ADs+ set  is  a  fertile  area  for  new 
experiments.  In form, our protocol is similar to that originally devised by Hart  et al. 
(36)  for suppressing CRI a, and because both CRI  ADs and CRI a are found on ABA- 
antibodies  in  the  sera  of unprimed  mice,  it  is  tempting  to  speculate  that  in  both 
instances, idiotype suppression in the anti-ABA-KLH response is initiated by boosting 
the endogenous response with antiidiotype. If this is true, then antiidiotype antibodies 
that  do  not  react  with  naturally  occurring  antibodies  might  not  induce  idiotype 
suppression  using  the  present  protocol  since  they  would  not  boost  an  endogenous 
response.  This  interpretation  could  also  apply  to the  recent  studies  of Nelles  et.  al. 
(38),  who made  three  monoclonal anti-CRI a antibodies  and  found  that  two  would 
induce suppression  whereas  the third  would not.  We would predict  that  the  former 
two antibodies  can  boost  the endogenous CRI a response but  that  the  third  cannot. 
This interpretation  could also be extended to the anti-staphylococcal nuclease system 
(Nase).  Here, priming with an antiidiotype antibody induces serum idiotype with no 
specificity for Nase. Immunization with Nase after giving antiidiotype antibody fails 
to reveal  suppression  (11).  The CRI  ADs and  Nase systems are similar  in  that  giving 
antiidiotype calls up idiotype with unknown antigen-binding specificities  (12). How- 
ever,  we would  postulate  that  in  the  Nase system,  the  antiidiotype  antibody  is  not 
boosting an  endogenous response.  Here  the  antiidiotype  would  be stimulating  a  de 
novo  response.  The  possible  connection  between  endogenous  immune  responses  and 
idiotype dominance in induced antihapten  responses has been made before in other 
systems  (8,  15).  The experiments  shown  above lend  further  credence  to this  notion. 
To date, we have been unable to identify the stimulus responsible for the endogenous 
CRI  ads.  However,  the  IgG subclass  restriction  to  IgG3 and  IgG2 suggests  that  the 
naturally  occurring  CRI  aDs  is  the  result  of a  TI-1  antibody  response  (35).  Such 
responses are very often elicited  by bacterial  antigens  that may be implicated  in the 
endogenous response reported here. Our findings are similar to those in the MOPC- 
460  system  where  the  endogenous  idiotype  was  dramatically  reduced  in  germ-free 
mice, implicating the endogenous flora as the relevant antigen  (8).  Unfortunately, no 
germ-free  strain  A  mice  are  available  to  do  a  similar  experiment.  We  are  now 
searching for the stimulus for the endogenous response. 
At first glance, it would seem that only those idiotopes originally called unspecific 
parallel  sets by Jerne  (13)  should function as regulatory idiotopes.  By definition,  the 
unspecific parallel  sets are idiotopes  that  are distinct  from the antigen-binding sites, 
and therefore, can be found on antibodies having dissimilar antigen-binding specific- 
ities.  The usual  criterion  for antigen-binding  site-associated  idiotopes  is  the  hapten PETER  V.  HORNBECK AND GEORGE K. LEWIS  1133 
inhibitability  of  the  idiotope  antiidiotope  interaction.  Our  data  on  the  hapten 
inhibitability of the AD8-CRI  ADs interaction demonstrate that the criterion of hapten 
inhibitability  should  be used  with  caution  for defining  binding  site-associated  idi- 
otopes.  In  our  experiments,  the  50%  hapten-inhibition  point  for  ADS  binding  to 
CRI  ADs varied  dramatically with  the  source of CRI  ADs. When  hybridoma protein 
R16.7  was used as the source of CRI  ADs, its interaction with AD8 was inhibited by 
relatively low concentrations of free hapten. On the other hand, when serum CRI or 
hybridoma protein  36-65  were used  as a  source of CRI  ADs, their interactions  with 
ADS  were  inhibited  by  only  very  high  concentrations  of  free  hapten.  In  other 
experiments, the same concentrations of free hapten inhibited the interaction between 
normal Ig and a  monoclonal antibody against IgG-Fc, suggesting that these hapten 
concentrations nonspecifically inhibit the AD8-CRI  ADs interaction. Thus, depending 
on the source of CRI  ADs, the AD8-CRI  ADs interaction can appear to be more or less 
binding-site specific. Within the limits imposed by our relatively small sample size, it 
appears that  the  strength  of the  AD8-CRI  ADs interaction  varies inversely with  the 
ease of hapten inhibition of this interaction. This statement is based on the observa- 
tions that hybridoma protein R16.7 interacted with ADS very poorly when compared 
with either serum idiotype or 36-65, whereas the interaction of AD8 and R16.7 was 
inhibited  by relatively low concentrations  of hapten when  compared with  the high 
hapten necessary to compete the interaction of ADS with either serum CRI or 36-65. 
These  findings  agree with  other reports  (7,  8)  showing  that  a  binding  site-related 
idiotope  can  be  found  on  antibodies  that  have  no  demonstrable  affinity  for  the 
original  hapten.  Furthermore,  such  an  idiotope  can  be  correlated  with  the  cross 
regulation of two immune responses, each being specific for a different epitope. At the 
present, it is only safe to say that CRI  ADs is correlated with the presence of a regulatory 
idiotope. It is not possible to say that CRI  ADs is a  regulatory idiotope since we have 
no  direct  data  that  the  actual  idiotope  recognized  by AD8  is,  in  fact,  the  same 
structure recognized by the regulatory elements of the immune system. Further studies 
using  antiidiotypic  T  cells,  autologous  antiidiotype  antibodies,  and  our  panel  of 
CRI  ADs÷ and CRI  ^Ds- hybridoma proteins will be required to answer this question. 
Summary 
A new cross-reactive idiotope family (CRI  ADs) is described that contains subpopu- 
lations of antibodies binding to different epitopes. One subpopulation occurs naturally 
in normal sera from strain A mice, is found mainly on IgG2 and IgGa subclasses, does 
not bind p-azobenzenearsonate (ABA) +, does not express CRI  5ci, and can be selectively 
stimulated by low doses of antiidiotype antibody (AD8). The second subpopulation 
is not  found in normal serum, binds ABA,  is  found on all IgG subclasses, expresses 
CRI  5ci, and is selectively stimulated by ABA-conjugated proteins. Since CRI  ADs was 
found on both subpopulations of antibody, and since each subpopulation could be 
selectively expanded,  it was possible to study the effect that expansion of the ABA- 
CRI  ADs+ set had on subsequent responses elicited by ABA-keyhole limpet hemocyanin 
(KLH) in the ABA  + CRI  ADs+ set. In these experiments, prior immunization with AD8 
restricted the subsequent  response of the ABA  + CRI  ADs+ set to ABA-KLH. Further- 
more, only those  doses of AD8 that stimulated  the ABA- CRI  ADs+ set reduced  the 
responsiveness  of the  ABA  +  CRI  ADs+ set  to  ABA-KLH,  suggesting  that  the  two 
phenomena  are causally related.  These findings  argue that  CRI  ADs correlates well 1134  IDIOTYPE  CONNECTANCE IN THE IMMUNE  SYSTEM 
with  a  regulatory idiotope and that  immune responses by lymphocyte clones that 
have different antigen-binding  specificities can affect one another as a  result of their 
sharing such an idiotope. These results strongly favor a  network organization of the 
immune system. 
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